CFOR CapForce Inc.

OTC Services-Medical Laboratories DE CIK: 0001293818
AI RATING
SELL
85% Confidence

Investment Thesis

CapForce demonstrates exceptional profitability metrics with 62.3% net margins and strong returns on equity (24.5%), but these gains are severely undermined by negative free cash flow of -$1.8M despite positive net income of $2.5M, indicating potential accounting quality issues or unsustainable capital structures. The company's high leverage (0.91x debt/equity) combined with deteriorating cash generation and minimal insider confidence (zero Form 4 filings in 90 days) raises red flags about the sustainability of reported earnings.

Strengths

  • + Exceptional net profit margin of 62.3% with revenue growth of 52% YoY
  • + Strong liquidity position with 7.06x current ratio and minimal cash requirements
  • + Excellent return metrics: 24.5% ROE and 19.7% ROA indicate efficient capital deployment
  • + Outstanding operating margin of 54.4% suggests pricing power and operational efficiency

Risks

  • ! Severe cash flow deterioration: negative $1.8M free cash flow contradicts $2.5M net income, indicating potential earnings quality concerns
  • ! Significant long-term debt of $9.2M (0.91x debt/equity) with only $414.2K cash on hand creates refinancing risk
  • ! Operating cash flow is deeply negative at -$978.7K, suggesting cash is being consumed rather than generated by operations
  • ! Zero insider Form 4 filings in 90 days indicates lack of insider confidence despite reported strong earnings
  • ! Capital expenditure of $800.4K against negative operating cash flow suggests unsustainable investment levels

Key Metrics to Watch

Financial Metrics

Revenue
4.0M
Net Income
2.5M
EPS (Diluted)
$0.24
Free Cash Flow
-1.8M
Total Assets
12.6M
Cash
414.2K

Profitability Ratios

Gross Margin 23.1%
Operating Margin 54.4%
Net Margin 62.3%
ROE 24.5%
ROA 19.7%
FCF Margin -44.5%

Balance Sheet & Liquidity

Current Ratio
7.06x
Quick Ratio
3.47x
Debt/Equity
0.91x
Debt/Assets
19.6%
Interest Coverage
248.12x
Long-term Debt
9.2M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-03-22T05:36:13.857352 | Data as of: 2025-09-30 | Powered by Claude AI